Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$9,396
+$4,263 QoQ
Shares Held
37
+76.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#4,649
of 4,664 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026POM Investment Strategies, LLC holds $642,919 across 10 Drug Manufacturers - General names. JNJ ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,492 | $375,446 | |
| 2 | PFE |
Pfizer Inc
|
3,000 | $72,240 | |
| 3 | MRK |
Merck & Co., Inc.
|
541 | $69,518 | |
| 4 | LLY |
ELI LILLY & Co
|
48 | $57,572 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
513 | $29,559 | |
| 6 | NVO |
Novo Nordisk A S
|
454 | $21,764 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
37 | $9,396 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
36 | $4,548 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,396 | 37 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $5,133 | 21 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $440,803 | 2,130 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $479,310 | 2,585 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $389,207 | 2,548 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $425,545 | 2,566 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $376,445 | 2,603 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $415,845 | 2,566 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $386,447 | 2,644 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $405,915 | 2,566 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $402,194 | 2,566 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||